Giraffe Bio
PrivateLast Round
Seed
Oct 13, 2026
Total Funding Raised
$7.56M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Giraffe Bio is a biotechnology company that uses AI and custom-engineered biomolecules to optimize metal extraction, increase yield, and reduce environmental impact for the mining industry.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Clean Manufacturing, Advanced Materials, Circular Economy, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Giraffe Bio Comparables
Compare Giraffe Bio with similar companies based on industry and business-model similarity.
Giraffe Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 13, 2026 | ||||
| Seed | Oct 14, 2025 | ||||
| Grant | Jul 10, 2025 |
Key People
Founding team and executive leadership
Giraffe Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start-Up Chile | Seed |
| Orion Industrial Ventures | Seed |
| Columbia University Tamer Fund for Social Ventures | Grant |
| Twynam | Seed |
| Baruch Future Ventures | Seed |
| IndieBio | Seed |
| AIR Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2026
$6.4M round led by Orion Industrial Ventures.
- Oct 5, 2026
Grew 40% QoQ from 10 to 14 employees.
Recent news
Latest coverage and updates
- receives_financingOct 13, 2026
On Oct 13th '26, Giraffe Bio receives a $6.4M Seed round led by Orion Industrial Ventures, with participation from BHP Ventures, Twynam, Air Capital, Baruch Future Ventures, and other investors, to validate and scale its mineral-specific reagent platform in Argentina and Chile.
Giraffe Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Giraffe Bio's valuation, stock price, and market status.
Is Giraffe Bio a public or private company?
Giraffe Bio is a private company.
What is the current stock price of Giraffe Bio?
Giraffe Bio is a private company, so its shares have no public market price. Caplight tracks Giraffe Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Giraffe Bio worth (valuation)?
Valuation information for Giraffe Bio is not publicly available.
Can I buy Giraffe Bio stock?
Giraffe Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Giraffe Bio's last funding round?
Giraffe Bio's most recent funding round was Seed on October 13, 2026.
Who are the main investors in Giraffe Bio?
Key investors in Giraffe Bio include Orion Industrial Ventures.
Will Giraffe Bio IPO soon?
No public IPO plans have been announced for Giraffe Bio.
How can I track Giraffe Bio secondary market activity?
Caplight tracks bids, offers, and trades in Giraffe Bio's shares on secondary markets.